Hope Rugo, MD

Hope Rugo is a leading medical oncologist in the breast cancer space whose work in clinical trials has led to approvals of antibody-drug conjugates, CDK4/6 inhibitors, PI3k inhibitors, PARP inhibitors, and checkpoint inhibitors, among others. Her work has also resulted in approvals of a scalp cooling cap preventative of chemotherapy-related hair loss along with a steroid mouthwash for the management of stomatitis.